Cargando…
Potential targets for next generation antimicrobial glycoconjugate vaccines
Cell surface carbohydrates have been proven optimal targets for vaccine development. Conjugation of polysaccharides to a carrier protein triggers a T-cell-dependent immune response to the glycan moiety. Licensed glycoconjugate vaccines are produced by chemical conjugation of capsular polysaccharides...
Autores principales: | Micoli, Francesca, Costantino, Paolo, Adamo, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995208/ https://www.ncbi.nlm.nih.gov/pubmed/29547971 http://dx.doi.org/10.1093/femsre/fuy011 |
Ejemplares similares
-
Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends
por: Micoli, Francesca, et al.
Publicado: (2018) -
Impact and Control of Sugar Size in Glycoconjugate Vaccines
por: Stefanetti, Giuseppe, et al.
Publicado: (2022) -
Glycoconjugate vaccines: classic and novel approaches
por: Adamo, Roberto
Publicado: (2021) -
Synthetic Glycans to Improve Current Glycoconjugate
Vaccines and Fight Antimicrobial Resistance
por: Del Bino, Linda, et al.
Publicado: (2022) -
Editorial: Glycoconjugates in vaccines and immunotherapeutics
por: Shivatare, Sachin, et al.
Publicado: (2022)